Frontiers in Psychiatry (Apr 2021)
Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
- Michael Specka,
- Thomas Kuhlmann,
- Jürgen Sawazki,
- Udo Bonnet,
- Renate Steinert,
- Monika Cybulska-Rycicki,
- Helmut Eich,
- Benita Zeiske,
- Antje Niedersteberg,
- Luzia Schaaf,
- Norbert Scherbaum
Affiliations
- Michael Specka
- LVR Hospital Essen Department of Addictive Behaviour and Addiction Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany
- Thomas Kuhlmann
- Psychosomatische Klinik Bergisch Gladbach, Bergisch Gladbach, Germany
- Jürgen Sawazki
- LVR Clinic Viersen, Viersen, Germany
- Udo Bonnet
- Castrop-Rauxel Evangelical Hospital, Castrop-Rauxel, Germany
- Renate Steinert
- LWL-Klinik Münster, Münster, North Rhine-Westphalia, Germany
- Monika Cybulska-Rycicki
- LVR Clinic Langenfeld, Langenfeld, Germany
- Helmut Eich
- Alexianer Hospital, Krefeld, Germany
- Benita Zeiske
- Alexius/Josef Hospital, Neuss, Germany
- Antje Niedersteberg
- LVR Clinic Düren, Düren, Germany
- Luzia Schaaf
- LVR Clinic Viersen, Viersen, Germany
- Norbert Scherbaum
- LVR Hospital Essen Department of Addictive Behaviour and Addiction Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany
- DOI
- https://doi.org/10.3389/fpsyt.2021.681542
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- novel psychoactive substances
- pregabalin abuse
- multiple substance use
- drug dependence
- drug detoxification
- opiate dependents